Understanding the neuroinflammatory response following concussion to develop treatment strategies

Frontiers in Cellular Neuroscience

Volumn , Issue NOV, 2012, Pages

  Patterson, Zachary R ^a   Holahan, Mathew R ^a  

^a CARLETON UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; BRAIN PROTEIN; DEXANABINOL; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 16; NESFATIN 1; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN CONCUSSION; BRAIN CONTUSION; CELL ACTIVATION; CYTOKINE RELEASE; CYTOKINE RESPONSE; DISEASE ASSOCIATION; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME SYNTHESIS; HUMAN; NERVE REGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRAUMATIC BRAIN INJURY; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 84871521963     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2012.00058     Document Type: Article

References (137)

1. Allan S.M., and Rothwell N.J. (2001). Cytokines and acute neuro degeneration. Nat Rev Neurosci 2:734-744.
2. Andersen, B.J., and Marmarou, A. (1992). Post-traumatic selective stimulation of glycolysis. Brain Res 585,184-189.
3. Anderson, T, Heitger, M., and Macleoud, A.D. (2006). Concussion and mild head injury. Practical Neurology 6, 342-357.
4. Andersson, E.H., Bjorklund, R., Emanuelson, I., and Stalhammar, D. (2003). Epidemiology of traumatic brain injury: a population based study in western Sweden. Acta NeurolScand 107,256-259.
5. Arnett, H.A., Mason, J., Marino, M., Suzuki, K, Matsushima, G.K., and Ting J P. (2001). TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4,1116-1122.
6. Aubry M., Cantu R., Dvorak J., Graf-Baumann, T., Johnston K, Kelly, J., Lovell M., Mccrory P., Meeuwisse W., Schamasch P., and Concussion in Sport, G. (2002). Summary and agreement statement of the First International Conference on Concussion in Sport, Vienna 2001. Recommendations for the improvement of safety and health of athletes who may suffer concussive injuries. Brj Sports Med36,6-10.
7. Babikian, T, Difiori J., and Giza, C.C. (2012). Chapter 5: Pathophysiological Outcomes. New York: The Guilford Press.
8. Barkhoudarian, G., Hovda, D.A., and Giza, C.C. (2011). The molecular pathophysiology of concussive brain injury. Clin Sports Med30,33-48, vii-iii.
9. Barone, F.C, and Parsons, A.A. (2000). Therapeutic potential of anti-inflammatory drugs in focal stroke. Expert Opin Investig Drugs 9,2281-2306.
10. Bazarian, T.J., Mcclung J., Shah, M.N., Cheng, Y.T., Flesher, W., and Kraus, J. (2005). Mild traumatic brain injury in the United States, 1998-2000. Brain InJ 19, 85-91.
11. Bazarian, J J., Zhong, J., Blyth, B., Zhu, T, Kavcic, V., and Peterson, D. (2007). Diffusion tensor imaging detects clinically important axonal damage after mild traumatic brain injury: a pilot study. J Neurotrauma 24,1447-1459.
12. Benveniste, E.N., Tang, L.P., and Law, R.M. (1995). Differential regulation ofastrocyte TNF-alpha expression by the cytokines TGF-beta, IL-6 and IL-10. IntjDev Neurosci 13,341-349.
13. Bermpohl, D., You, Z., ho, E.H., Kim, H.H., and Whalen, M.J. (2007). TNF alpha and Fas mediate tissue damage and functional outcome after traumatic brain injury in mice. JCereb Blood Flow Metab 27,1806-1818.
14. Biegon, A., and Joseph, A.B. (1995). Development of HU-211 as a neuroprotectant for ischemic brain damage. Neurol Res 17,275-280.
15. Bonnet, M.S., Pecchi, E., Trouslard, J., Jean, A., Dallaporta, M., and Troadec, J.D. (2009). Central nesfatin-1-expressing neurons are sensitive to peripheral inflammatory stimulus. J Neuroinflammation 6,27.
16. Browne, K.D., Iwata, A., Putt, M.E., and Smith, D.H. (2006). Chronic ibuprofen administration worsens cognitive outcome following traumatic brain injury in rats. Exp Neurol201,301-307.
17. Campbell, I.L., Abraham, C.R., Masliah, E., Kemper, P., Inglis, J.D., Oldstone, M.B., and Mucke, L. (1993). Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci U SA90,10061-10065.
18. Cantu, R.C., Aubry, M., Dvorak, J., Graf-Baumann, T., Johnston, K, Kelly, J., Lovell, M., Mccrory, P., Meeuwisse, W., Schamasch, P., Kevin, M., Bruce, S.L., Ferrara, M.S., Kelly, J.P., Mccrea, M., Putukian, M., and Mcleod, T.C (2006). Overview of concussion consensus statements since 2000. Neurosurg Focus 21, E3.
19. Cantu, R.C., and Register-Mihalik, J.K. (2011). Considerations for return-to-play and retirement decisions after concussion. PM R 3, S440-444.
20. Chao, C.C., Hu, S., Ehrlich, L., and Peterson, P.K (1995a). Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and ofN-methyl-D-aspartate receptors. Brain Behav Immun 9,355-365
21. Chao, C.C., Hu, S., Sheng, W.S., Tsang, M., and Peterson, P.K. (1995b). Tumor necrosis factor-alpha mediates the release ofbioactive transforming growth factor-beta in murine microglial cell cultures. Clin Immunol Immunopathol 77,358-365.
22. Clausen, F., Hanell, A., Bjork, M., Hillered, L., Mir, A.K, Gram, H, and Marklund, N. (2009). Neutralization of interleukin-1 beta modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice. Eur J Neurosci 30,385-396.
23. Clausen, F., Hanell, A., Israelsson, C, Hedin, J., Ebendal, T, Mir, A.K, Gram, H, and Marklund, N. (2011). Neutralization of interleukin-lbeta reduces cerebral edema and tissue loss and improves late cognitive outcome following traumatic brain injury in mice. Eur] Neurosci 34,110-123.
24. Comper, P., Bisschop, S.M., Carnide, N., and Tricco, A. (2005). A systematic review of treatments for mild traumatic brain injury. Brain InJ 19, 863-880.
25. Cortez, S.C, Mcintosh, T.K, and Noble, L.J. (1989). Experimental fluid percussion brain injury: vascular disruption and neuronal andglial alterations. Brain Res 482, 271-282.
26. Csuka, E., Hans, V.H., Ammann, E., Trentz, O., Kossmann, T, and Morganti-Kossmann, M.C (2000). Cell activation and inflammatory response following traumatic axonal injury in the rat. Neuroreportll, 2587-2590.
27. Csuka, E., Morganti-Kossmann, M.C, Lenzlinger, P.M., joller, H, Trentz, O., and Kossmann, T (1999). IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-betal and blood-brain barrier function. JN euroimmunol 101,211-221.
28. Dalgard, C.L., Cole, J.T., Kean, W.S., Lucky, J.J., Sukumar, G., McmuUen, D.C, Pollard, H.B., and Watson, W.D. (2012). The cytokine temporal profile in rat cortex after controlled cortical impact. Front Mol Neurosci 5, 6.
29. Davalos, D., Grutzendler, J., Yang, G., Kim, J.V., Zuo, Y., Jung, S., Littman, D.R., Dustin, M.L., and Gan, W.B. (2005). ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8, 752-758.
30. Davis, G.A., Iverson, G.L., Guskiewicz, KM., Ptito, A., and Johnston, KM. (2009). Contributions of neuroimaging, balance testing, electrophysiology and blood markers to the assessment of sport-related concussion. BrJ Sports Med 43 Suppl 1, i36-45.
31. Deford, S.M., Wilson, M.S., Rice, A.C., Clausen, T, Rice, L.K, Barabnova, A., Bullock, R., and Hamm, RJ. (2002). Repeated mild brain injuries result in cognitive impairment in B6C3F1 mice, j Neurotrauma 19, 427-438.
32. Dekosky, S.T., Styren, S.D., O'malley, M.E., Goss, J.R, Kochanek, P., Marion, D., Evans, C.H., and Robbins, P.D. (1996). Interleukin-1 receptor antagonist suppresses neurotrophin response in injured rat brain. Ann Neurol39,123-127.
33. Difiori, J.P., and Giza, C.C. (2010). New techniques in concussion imaging. Curr Sports Med Rep 9,35-39.
34. Fan, L., Young, P.R, Barone, F.C, Feuerstein, G.Z., Smith, D.H., and Mcintosh, T.K (1995). Experimental brain injury induces expression of interleukin-1 beta mRNA in the rat brain. Brain Res Mol Brain Res 30,125-130.
35. Fan, L., Young, P.R, Barone, F.C, Feuerstein, G.Z., Smith, D.H., and Mcintosh, T.K. (1996). Experimental brain injury induces differential expression of tumor necrosis factor-alpha mRNA in the CNS. Brain Res Mol Brain Res 36,287-291.
36. Farkas, O., Lifshitz, J., and Povlishock, J.T. (2006). Mechanoporation induced by diffuse traumatic brain injury: an irreversible or reversible response to injury? J Neurosci 26,3130-3140.
37. Fassbender, K, Schneider, S., Bertsch, T, Schlueter, D., Fatar, M., Ragoschke, A., Kuhl, S., Kischka, U., and Hennerici, M. (2000). Temporal profile of release of interleukin- lbeta in neurotrauma. Neurosci Lett 284,135-138.
38. Feinstein, A., and Rapoport, M. (2000). Mild traumatic brain injury: the silent epidemic. Can J Public Health 91,325-326, 332.
39. Field, M., Collins, M.W., Lovell, M.R, and Maroon,]. (2003). Does age play a role in recovery from sports-related concussion? A comparison of high school and collegiate athletes, j Pediatr 142, 546-553.
40. Fineman, I., Giza, C.C, Nahed, B.V., Lee, S.M., and Hovda, D.A. (2000). Inhibition of neocortical plasticity during development by a moderate concussive brain injury, j Neurotrauma 17, 739-749.
41. Fukuda, K, Tanno, H., Okimura, Y., Nakamura, M., and Yamaura, A. (1995). The blood-brain barrier disruption to circulating proteins in the early period after fluid percussion brain injury in rats, j Neurotrauma 12, 315-324.
42. Gadient, R.A., Cron, K.C., and Otten, U. (1990). Interleukin-1 beta and tumor necrosis factor-alpha synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes. Neurosci Lett 117,335-340.
43. Galic, M.A., Riazi, K, and Pittman, Q.J. (2012). Cytokines and brain excitability. Front Neuroendocrinol 33,116-125.
44. Gardiner, M., Smith, M.L., Kagstrom, E., Shohami, E., andSiesjo, B.K (1982). Influence of blood glucose concentration on brain lactate accumulation during severe hypoxia and subsequent recovery of brain energy metabolism, j Cereb Blood Flow Metab 2, 429-438.
45. Gentleman, S.M., Leclercq, P.D., Moyes, L., Graham, D.I., Smith, C., Griffin, W.S., and Nicoll,J.A. (2004). Long-term intracerebral inflammatory response after traumatic brain injury. Forensic Sci Int 146, 97-104.
46. Giza, C.C., and Difiori, J.P. (2011). Pathophysiology of sports-related concussion: an update on basic science and translational research. Sports Health 3, 46-51.
47. Giza, C.C., and Hovda, D.A. (2001). The Neurometabolic Cascade of Concussion, jAthl Train 36, 228-235.
48. Goldberg, A.S., Moroz, L., Smith, A., and Ganley, T (2007). Injury surveillance in young athletes: a clinician'sguide to sports injury literature. Sports Med 37,265-278.
49. Gosselin, N., Saluja, R.S., Chen J.K., Bottari, C, Johnston, K, and Ptito, A. (2010). Brain functions after sports-related concussion: insights from event-related potentials and functional MRI. Phys Sportsmed 38, 27-37.
50. Gurkoff G.G., Giza, C.C., and Hovda, D.A. (2006). Lateral fluid percussion injury in the developing rat causes an acute, mild behavioral dysfunction in the absence of significant cell death. Brain Res 1077, 24-36.
51. Habgood, M.D., Bye, N., Dziegielewska, KM., Ek, C.J., Lane, M.A., Potter, A., Morganti- Kossmann, C, and Saunders, N.R. (2007). Changes in blood-brain barrier permeability to large and small molecules following traumatic brain injury in mice. Eurj Neurosci 25, 231-238.
52. Herx, L.M., Rivest, S., and Yong, V.W. (2000). Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1 beta is required for the production of ciliary neurotrophic factor, j Immunol 165, 2232-2239.
53. Holmin, S., Schalling, M., Hojeberg, B., Nordqvist, A.C, Skeftruna, A.K., and Mathiesen, T. (1997). Delayed cytokine expression in rat brain following experimental contusion, jNeurosurg 86, 493-504.
54. Holmin, S., Soderlund, J., Biberfeld, P., and Mathiesen, T. (1998). Intracerebral inflammation after human brain contusion. Neuro surgery 42,291-298; discussion 298-299.
55. Ibrahim, N.G., Ralston, J., Smith, C, and Margulies, S.S. (2010). Physiological and pathological responses to head rotations in toddler piglets. J Neurotrauma 27, 1021-1035
56. Inglese, M., Makani, S., Johnson, G., Cohen, B.A., Silver, J.A., Gonen, O., and Grossman, R.I. (2005). Diffuse axonal injury in mild traumatic brain injury: a diffusion tensor imaging study, j Neurosurg 103,298-303.
57. Jeter, C.B., Hergenroeder, G.W., Hylin, M.J., Redell J.B., Moore, A.N., and Dash, P.K. (2012). Biomarkers for the diagnosis and prognosis of mild traumatic brain injury/concussion. J Neurotrauma.
58. Kabadi, S.V., Stoica, B.A., Byrnes, K.R., Hanscom, M., Loane, D.J., and Faden, A.I. (2012). Selective CDK inhibitor limits neuroinflammation and progressive neurodegeneration after brain trauma. J Cereb Blood Flow Metab 32,137-149.
59. Kalimo, H, Rehncrona, S., and Soderfeldt, B. (1981). The role of lactic acidosis in the ischemic nerve cell injury. Acta Neuropathol Suppl 7, 20-22.
60. Katayama, Y., Becker, D.P., Tamura, T, and Hovda, D.A. (1990). Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury. J Neurosurg 73, 889-900.
61. Kawamata, T, Katayama, Y., Hovda, D.A., Yoshino, A., and Becker, D.P. (1992). Administration of excitatory amino acid antagonists via microdialysis attenuates the increase in glucose utilization seen following concussive brain injury. J Cereb Blood Flow Metab 12,12-24.
62. Khuman, J., Meehan, W.P., 3rd, Zhu, X., Qiu, J., Hoffmann, U., Zhang, J., Giovannone, E., ho, E.H., and Whalen, M.J. (2011). Tumor necrosis factor alpha and Fas receptor contribute to cognitive deficits independent of cell death after concussive traumatic brain injury in mice, j Cereb Blood Flow Metab 31, 778-789.
63. Kim, K.S., Wass, C.A., Cross, AS., and Opal, S.M. (1992). Modulation of blood-brain barrier permeability by tumor necrosis factor and antibody to tumor necrosis factor in the rat. Lymphokine Cytokine Res 11,293-298.
64. Kirchhoff C, Buhmann, S., Bogner, V., Stegmaier, J., Leidel, B.A., Braunstein, V., Mutschler, W., and Biberthaler, P. (2008). Cerebrospinal IL-10 concentration is elevated in non-survivors as compared to survivors after severe traumatic brain injury. EurjMed Res 13, 464-468.
65. Knoblach, S.M., and Faden, A.I. (1998). Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. Exp Neurol 153,143-151.
66. Knoblach, S.M., Fan, L., and Faden, A.I. (1999). Early neuronal expression of tumor necrosis factor-alpha after experimental brain injury contributes to neurological impairment, j Neuroimmunol 95,115-125.
67. Kolesnick, R, and Golde, D.W. (1994). The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77,325-328.
68. Kopf M., Baumann, H, Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T, Zinkernagel, R, Bluethmann, H, and Kohler, G. (1994). Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368,339-342.
69. Kossmann, T, Hans, V., Imhof H.G., Trentz, O., and Morganti-Kossmann, M.C. (1996). Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Res 713, 143-152.
70. Kossmann, T, Hans, V.H., Imhof, H.G., Stocker, R, Grob, P., Trentz, O., and Morganti-Kossmann, C (1995). Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries. Shock 4,311-317.
71. Kremlev, S.G., and Palmer, C (2005). Interleukin-10 inhibits endotoxin-induced pro-inflammatory cytokines in microglial cell cultures, J Neuroimmunol 162, 71 -80.
72. Kumar, A., and Loane, D.j. (2012). Neuroinflammation after traumatic brain injury: Opportunities for therapeutic intervention. Brain Behav Immun.
73. Kushima, Y., Hama, T, and Hatanaka, H. (1992). Interleukin-6 as a neurotrophic factor for promoting the survival of cultured catecholaminergic neurons in a chemically defined medium from fetal and postnatal rat midbrains. Neurosci Res 13, 267-280.
74. Kutcher, J.S., Giza, C.C., and Alessi, A.G. (2010). Sports concussion. Continuum (Minneap Minn) 16, 41-54.
75. Laker, S.R (2011). Return-to-play decisions. Phys Med Rehabil Clin N Am 22, 619-634, viii.
76. Ledic, D., Sosa, L, Linic, IS., Cvijanovic, O., Kovacevic, M., Desnica, A., and Banicek, I. (2012). Vomiting as a reliable sign of concussion. Med Hypotheses 78,23-25.
77. Lenzlinger, P.M., Morganti-Kossmann, M.C., Laurer, H.L., and Mcintosh, T.K. (2001). The duality of the inflammatory response to traumatic brain injury. Mol Neurobiol 24,169-181.
78. Ley, E.J., Clond, M.A., Singer, M.B., Shouhed, D., andSalim, A. (2011). IL6 deficiency affects function after traumatic brain injury. J Surg Res 170,253-256.
79. Lowrance, J.H., O'sullivan, F.X., Caver, T.E., Waegell, W., and Gresham, H.D. (1994). Spontaneous elaboration of transforming growth factor beta suppresses host defense against bacterial infection in autoimmune MRL/lpr mice, j Exp Med 180,1693-1703.
80. Lyng, K, Munkeby, B.H., Saugstad, O.D., Stray-Pedersen, B., and Froen, J.F. (2005). Effect of interleukin-10 on newborn piglet brain following hypoxia-ischemia and endotoxin-induced inflammation. Biol Neonate 87,207-216.
81. Maas, A.I., Murray, G., Henney, H, 3rd, Kassem, N., Legrand, V, Mangelus, M., Muizelaar, J.P., Stocchetti, N., Knoller, N., and Pharmos, T.B.I.I. (2006). Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial. Lancet Neurol 5, 38-45.
82. Maier, B., Laurer, H.L., Rose, S., Buurman, W.A., and Marzi, I. (2005). Physiological levels of pro- and anti-inflammatory mediators in cerebrospinal fluid and plasma: a normative study, j Neurotrauma 22, 822-835.
83. Martin, N.A., Patwardhan, RV, Alexander, M.J., Africk, C.Z., Lee, J.H., Shalmon, E., Hovda, D.A., and Becker, D.P. (1997)., hyperemia Characterization of cerebral hemodynamic phases following severe head trauma: hypoperfusion, and vasospasm. j Neurosurg 87, 9-19.
84. Maskin, B., Gammella, D., Solari, L., Videta, W., Barboza, M.F., Geliz, L., and Rondina, C (2001). [Early release of the antiinflammatory cytokine IL-10 in traumatic brain injury]. Medicina (B Aires) 61, 573-576.
85. Mccrea, M., Hammeke, T, Olsen, G., Leo, P., and Guskiewicz, K. (2004). Unreported concussion in high school football players: implications for prevention. Clinj Sport Med 14,13-17.
86. Mccrory, P., Meeuwisse, W., Johnston, K., Dvorak, J., Aubry, M., Molloy, M., and Cantu, R. (2009). Consensus statement on concussion in sport: the 3rd International Conference on Concussion in Sport held in Zurich, November 2008. J Athl Train 44, 434-448.
87. Mccullough, B.J., and Jarvik, J.G. (2011). Diagnosis of concussion: the role of imaging now and in the future. Phys Med Rehabil Clin N Am 22, 635-652, viii.
88. Metting, Z., Wilczak, N, Rodiger, L.A., Schaaf J.M., and Van DerNaalt, J. (2012). GFAP and SI OOB in the acute phase of mild traumatic brain injury. Neurology 78, 1428-1433.
89. Morganti-Kossmann, M.C, Hans, V.H., Lenzlinger, P.M., Dubs, R., Ludwig, E., Trentz, O., and Kossmann, T. (1999). TGF-beta is elevated in the CSF of patients with severe traumatic brain injuries and parallels blood-brain barrier function, j Neurotrauma 16, 617-628.
90. Morganti-Kossmann, M.C., Rancan, M., Otto, V.I., Stahel, P.F., and Kossmann, T. (2001). Role of cerebral inflammation after traumatic brain injury: a revisited concept. Shock 16,165-177.
91. Mustoe, T.A., Pierce, G.F., Thomason, A., Gramates, P., Sporn, M.B., and Deuel, T.F. (1987). Accelerated healing ofincisional wounds in rats induced by transforming growth factor-beta. Science 237,1333-1336.
92. O'connor, W.T., Smyth, A., and Gilchrist, M.D. (2011). Animal models of traumatic brain injury: a critical evaluation. Pharmacol Therl30,106-113.
93. Penkowa, M., Camats, J., Hadberg, H, Quintana, A., Rojas, S., Giralt, M., Molinero, A., Campbell, I.L., and Hidalgo, J. (2003). Astrocyte-targeted expression of interleukin-6 protects the central nervous system during neuroglial degeneration induced by 6-aminonicotinamide. j Neurosci Res 73, 481-496.
94. Penkowa, M., Giralt, M., Carrasco, J., Hadberg, H, and Hidalgo, J. (2000). Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6-deficient mice. Glia 32,271-285.
95. Perry, R.T., Collins, J.S., Wiener, H, Acton, R, and Go, RC (2001). The role ofTNFand its receptors in Alzheimer's disease. Neurobiol Aging 22, 873-883.
96. Prins, M.L., Hales, A., Reger, M., Giza, C.C., and Hovda, D.A. (2010). Repeat traumatic brain injury in the juvenile rat is associated with increased axonal injury and cognitive impairments. Dev Neurosci 32, 510-518.
97. Pulsipher, D.T., Campbell, RA., Thoma, R., and King J.H. (2011). A critical review of neuroimaging applications in sports concussion. Curr Sports Med Rep 10,14-20.
98. Putukian, M. (2011). Neuropsychological testing as it relates to recovery from sports-related concussion. PM R 3, S425-432.
99. Quintana, A., Molinero, A., Borup, R., Nielsen, F.C, Campbell, I.L., Penkowa, M., and Hidalgo, J. (2008). Effect of astrocyte-targeted production ofIL-6 on traumatic brain injury and its impact on the cortical transcriptome. Dev Neurobiol 68, 195-208.
100. Ramilo, O., Saez-Llorens, X., Mertsola, J., Jafari, H, Olsen, K.D., Hansen, E.J., Yoshinaga, M., Ohkawara, S., Nariuchi, H, and Mccracken, G.H.,jr. (1990). Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation. J Exp Med 172, 497-507.
101. Ramlackhansingh, A.F., Brooks, D.J., Greenwood, R.J., Bose, S.K, Turkheimer, F.E., Kinnunen, KM., Gentleman, S., Heckemann, RA., Gunanayagam, K, Gelosa, G., and Sharp, D.J. (2011). Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol 70,374-383.
102. Randolph, C, Millis, S., Barr, W.B., Mccrea, M., Guskiewicz, KM., Hammeke, T.A., and Kelly, J.P. (2009). Concussion symptom inventory: an empirically derived scale for monitoring resolution of symptoms following sport-related concussion. Arch Clin Neuropsychol 24,219-229.
103. Scherbel, U., Raghupathi, R., Nakamura, M., Saatman, K.E., Trojanowski, J.Q., Neugebauer, E., Marino, M.W., and Mcintosh, T.K (1999). Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc NatlAcadSci USA 96, 8721-8726.
104. Schiff, L., Hadker, N., Weiser, S., and Rausch, C. (2012). A literature review of the feasibility ofglialfibrillary acidic protein as a biomarker for stroke and traumatic brain injury. MolDiagn Therló, 79-92.
105. Scorza, K.A., Raleigh, M.F., and O'connor, F.G. (2012). Current concepts in concussion: evaluation and management. Am Earn Physician 85,123-132.
106. Shiozaki, T., Hayakata, T., Tasaki, O., Hosotubo, H., Fuijita, K, Mouri, T., Tajima, G., Kajino, K, Nakae, H., Tanaka, H., Shimazu, T., and Sugimoto, H. (2005). Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury. Shock 23, 406-410.
107. Shohami, E., Bass, R, Wallach, D., Yamin, A., and Gallily, R. (1996). Inhibition of tumor necrosis factor alpha (TNFalpha) activity in rat brain is associated with cerebroprotection after closed head injury, j Cereb Blood Flow Metab 16,378- 384.
108. Shohami, E., Gallily, R, Mechoulam, R., Bass, R., and Ben-Hur, T. (1997). Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant. j Neuroimmunol 72,169-177.
109. Shohami, E., Ginis, I., and Hallenbeck, J.M. (1999). Dual role of tumor necrosis factor alpha in brain injury. Cytokine Growth Factor Rev 10,119-130.
110. Shohami, E., Novikov, M., Bass, R, Yamin, A., and Gallily, R (1994). Closed head injury triggers early production ofTNF alpha and IL-6 by brain tissue, j Cereb Blood Flow Metab 14, 615-619.
111. Shojo, H., Kaneko, Y., Mabuchi, T., Kibayashi, K, Adachi, N., and Boriongan, C.V. (2010). Genetic and histologic evidence implicates role of inflammation in traumatic brain injury-induced apoptosis in the rat cerebral cortex following moderate fluid percussion injury. Neuroscience 171,1273-1282.
112. Singh, S., Swarnkar, S., Goswami, P., and Nath, C (2011). Astrocytes and microglia: responses to neuropathological conditions. IntjNeurosci 121, 589-597.
113. Slobounov, S., Sebastianelli, W., and Hallett, M. (2012). Residual brain dysfunction observed one year post-mild traumatic brain injury: Combined EEG and balance study. Clin Neurophysiol 123,1755-1761.
114. Stirling, D.P., Khodarahmi, K, Liu, J., Mcphail, L.T., Mcbride, C.B., Steeves, J.D., Ramer, M.S., and Tetzlaff W. (2004). Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury, j Neurosci 24,2182-2190.
115. Sullivan, P.G., Bruce-Keller, A.J., Rabchevsky, A.G., Christakos, S., Clair, D.K, Mattson, M.P., and Scheff S.W. (1999). Exacerbation of damage and altered NF-kappaB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury, j Neurosci 19, 6248-6256.
116. Szmydynger-Chodobska, J., Strazielle, N., Gandy J.R., Keefe, T.H., Zink, B.J., Ghersi-Egea, J.F., and Chodobski, A. (2012). Posttraumatic invasion ofmonocytes across the blood-cerebrospinal fluid barrier, j Cereb Blood Flow Metab 32, 93-104.
117. Takahashi, H., Manaka, S., andSano, K (1981). Changes in extracellular potassium concentration in cortex and brain stem during the acute phase of experimental closed head injury, j Neurosurg 55, 708-717.
118. Tang, C.H., Fu, X.J., Xu, X.L., Wei, X.J., and Pan, H.S. (2012). The anti-inflammatory and anti-apoptotic effects ofnesfatin-1 in the traumatic rat brain. Peptides 36,39-45.
119. Tanno, H., Nockels, RP., Pitts, L.H., and Noble, L.J. (1992). Breakdown of the blood-brain barrier after fluid percussive brain injury in the rat. Part 1: Distribution and time course of protein extravasation. J Neurotrauma 9, 21-32.
120. Taupin, V., Toulmond, S., Serrano, A., Benavides, J., and Zavala, F. (1993). Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J Neuroimmunol 42,177-185.
121. Tavazzi, B., Vagnozzi, R., Signoretti, S., Amorini, A.M., Belli, A., Cimatti, M., Delflni, R., di Pietro, V., Finocchiaro, A., and Lazzarino, G. (2007). Temporal window of metabolic brain vulnerability to concussions: oxidative and nitrosative stresses--partll. Neurosurgery 61, 390-395; discussion 395-396.
122. Vanden Berghe, W., Vermeulen, L., De Wilde, G., De Bosscher, K, Boone, E., and Haegeman, G. (2000). Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. Biochem Pharmacol 60, 1185-1195
123. Vos, P.E., Jacobs, B., Andriessen, T.M., Lamers, K.J., Borm, G.F., Beems, T, Edwards, M., Rosmalen, C.F., and Vissers, J.L. (2010). GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study. Neurology 75,1786-1793.
124. Wahl, S.M. (1992). Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure, j Gin Immunol 12, 61-74.
125. Wahl, S.M. (1994). Transforming growth factor beta: the good, the bad, and the ugly.] ExpMed 180,1587-1590.
126. Wang, X, and Feuerstein, G.Z. (2000). Role of immune and inflammatory mediators in CNS injury. Drug News Perspect 13,133-140.
127. Werner, C, and Engelhard, K. (2007). Pathophysiology of traumatic brain injury. BrJ Anaesth 99, 4-9.
128. Winter, CD., lannotti, F., Pringle, A.K., Trikkas, C, Clough, G.F., and Church, M.K. (2002). A microdialysis method for the recovery oflL-lbeta, IL-6 and nerve growth factor from human brain in vivo, j Neurosci Methods 119, 45-50.
129. Woodroofe, M.N., Sarna, G.S., Wadhwa, M., Hayes, CM., Loughlin, A.J., Tinker, A., and Cuzner, M.L. (1991). Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production, j Neuroimmunol 33,227-236.
130. Wu J.P., Kuo J.S., Liu, Y.L., and Tzeng, S.F. (2000). Tumor necrosis factor-alpha modulates the proliferation of neural progenitors in the subven tricular/ven tricular zone of adult rat brain. Neurosci Lett 292,203-206.
131. Wu, Z., Zhang, J., and Nakanishi, H. (2005). Leptomeningeal cells activate microglia and astrocytes to induce IL-10 production by releasing pro-inflammatory cytokines during systemic inflammation. J Neuroimmunol 167, 90-98.
132. Xiong, Y., Gu, Q., Peterson, PL., Muizelaar, J.P., and Lee, C.P. (1997). Mitochondrial dysfunction and calcium perturbation induced by traumatic brain injury.J Neurotrauma 14,23-34.
133. Yang, J., You, Z., Kim, H.H., Hwang, S.K, Khuman, J., Guo, S., Lo, E.H., and Whalen, M.J. (2010). Genetic analysis of the role of tumor necrosis factor receptors in functional outcome after traumatic brain injury in mice.] Neurotrauma 27, 1037-1046.
134. Yoshino, A., Hovda, D.A., Kawamata, T., Katayama, Y., and Becker, D.P. (1991). Dynamic changes in local cerebral glucose utilization following cerebral conclusion in rats: evidence of a hyper- and subsequent hypometabolic state. Brain Res 561, 106-119.
135. Yu, C.H., Yhee, J.Y., Kim, J.H, Im, K.S., Kim, N.H., Jung, D.I., Lee, H.C., Chon, S.K, and Sur, J.H. (2011). Pro- and anti-inflammatory cytokine expression and histopathological characteristics in canine brain with traumatic brain injury.J Vet Sci 12, 299-301.
136. Ziebell, J.M., and Morganti-Kossmann, M.C. (2010). Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 7,22-30.
137. Zurek J., and Fedora, M. (2012). The usefulness ofSlOOB, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury. Acta Neurochir (Wien) 154, 93-103; discussion 103.